Disease-Specific iPS Cell Models in Neuroscience

Author(s): M. Peitz, J. Jungverdorben, O. Brustle.

Journal Name: Current Molecular Medicine

Volume 13 , Issue 5 , 2013

Become EABM
Become Reviewer


Neurodegenerative diseases are a heterogeneous group of sporadic or familial disorders of the nervous system that mostly lead to a progressive loss of neural cells. A major challenge in studying the molecular pathomechanisms underlying these disorders is the limited experimental access to disease-affected human nervous system tissue. In addition, considering that the molecular disease initiation occurs years or decades before the symptomatic onset of a medical condition, these tissues mostly reflect only the final phase of the disease. To overcome these limitations, various model systems have been established based on gainand loss-of-function studies in transformed cell lines or transgenic animal models. Although these approaches provide valuable insights into disease mechanisms and development they often lack physiological protein expression levels and a humanized context of molecular interaction partners. The generation of human induced pluripotent stem (hiPS) cells from somatic cells provides access to virtually unlimited numbers of patient-specific cells for modeling neurological disorders in vitro. In this review, we focus on the current progress made in hiPS cell-based modeling of neurodegenerative diseases and discuss recent advances in the quality assessment of hiPS cell lines.

Keywords: Induced pluripotent stem (iPS) cells, in vitro disease modeling, neurological disorder, neuroscience.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Page: [832 - 841]
Pages: 10
DOI: 10.2174/1566524011313050014
Price: $58

Article Metrics

PDF: 25